 | Up a level |
Coutelle, O., Schiffmann, L. M., Liwschitz, M., Brunold, M., Goede, V., Hallek, M., Kashkar, H. and Hacker, U. T. (2015). Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalisation without inducing empty basement membrane sleeves in xenograft tumours. Br. J. Cancer, 112 (3). S. 495 - 504. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827
Coutelle, O., Schiffmann, L. M., Liwschitz, M., Brunold, M., Goede, V., Hallek, M., Kashkar, H. and Hacker, U. T. (2015). Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalisation without inducing empty basement membrane sleeves in xenograft tumours. Br. J. Cancer, 112 (3). S. 495 - 504. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827
Schiffmann, L. M., Brunold, M., Liwschitz, M., Goede, V., Loges, S., Wroblewski, M., Quaas, A., Alakus, H., Stippel, D., Bruns, C. J., Hallek, M., Kashkar, H., Hacker, U. T. and Coutelle, O. (2017). A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition. Br. J. Cancer, 116 (5). S. 600 - 609. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827